12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
Showing 1 - 25 of >10,000
Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture Trial in Pittsburgh (Romosozumab, Placebo, Zoledronic acid)
Recruiting
- Osteoporosis
- +2 more
- Romosozumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Senior Communities
Sep 7, 2022
Osteopenia, Osteoporosis, Postmenopausal Osteoporosis Trial in Birmingham (Exercise training)
Not yet recruiting
- Osteopenia
- +3 more
- Exercise training
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 16, 2022
Postmenopausal Osteoporosis Trial in Worldwide (Romozosumab, Teriparatide)
Completed
- Postmenopausal Osteoporosis
-
Gainesville, Georgia
- +49 more
Nov 4, 2022
Bone Loss, Bone Loss, Age-related, Osteoporosis Trial (Resistance Training)
Not yet recruiting
- Bone Loss
- +3 more
- Resistance Training
- (no location specified)
Jul 17, 2023
Osteoporosis, Postmenopausal Trial in Copenhagen, Køge (Maltodextrin, Calcium-carbonate, Calcium-enriched permeate)
Active, not recruiting
- Osteoporosis, Postmenopausal
- Maltodextrin
- +3 more
-
Copenhagen, Frederiksberg, Denmark
- +1 more
Jul 22, 2022
Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With
Completed
- Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis
- exercises
-
Belgrade, SerbiaTamara Filipovic
Nov 14, 2022
Osteoporosis Risk Trial in Salerno (bicarbonate-calcium water)
Completed
- Osteoporosis Risk
- bicarbonate-calcium water
-
Salerno, ItalyUniversity of Salerno
May 2, 2023
Osteoporosis Risk Trial in Gölhisar (Exercise)
Completed
- Osteoporosis Risk
- Exercise
-
Gölhisar, Burdur, TurkeyBurdur Mehmet Akif Ersoy University
Oct 10, 2023
Postmenopausal Osteopenia Trial in Lahore (Kinect Based Virtual Reality Training, Control Group)
Recruiting
- Postmenopausal Osteopenia
- Kinect Based Virtual Reality Training
- Control Group
-
Lahore, Punjab, PakistanRiaz
Nov 24, 2022
Postmenopausal Osteoporosis, Hypovitaminosis D, Hyperparathyroidism Trial in Mexico City (Risedronate, Vitamin D)
Completed
- Postmenopausal Osteoporosis
- +2 more
- Risedronate
- Vitamin D
-
Mexico City, MexicoPeri-postmenopause and bone metabolism clinic. Regional Hospital
Apr 20, 2022
Male Osteoporosis Trial in San Francisco (Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, tablet)
Recruiting
- Male Osteoporosis
- Teriparatide or human parathyroid hormone (PTH) 1-34
- +4 more
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Dec 8, 2021
Osteoporosis, Osteoarthritis Trial in Loughborough (Ballistic Resistance Lower Body Strength Training, Conventional Resistance
Active, not recruiting
- Osteoporosis
- Osteoarthritis
- Ballistic Resistance Lower Body Strength Training
- Conventional Resistance Lower Body Strength Training
-
Loughborough, Leicestershire, United KingdomLoughborough University
Jun 2, 2023
Menopausal Status in Gynecological Malignancy After Ovariectomy
Not yet recruiting
- Gynecological Malignancies
- +2 more
- No intervention
- (no location specified)
Nov 28, 2023
Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu
Completed
- Postmenopausal Osteopenia
- +4 more
-
Lahore, Punjab, PakistanSaima Riaz
Jun 15, 2022
Post-Menopausal Women Trial in Maastricht (Olive Leaf Extract, Cellulose)
Recruiting
- Post-Menopausal Women
- Olive Leaf Extract
- Cellulose
-
Maastricht, Limburg, NetherlandsMaastricht University
Feb 15, 2023
Diabetes, Type 2, Osteoporosis Trial in New York (Denosumab 60 mg/ml [Prolia], Placebo)
Terminated
- Diabetes Mellitus, Type 2
- Osteoporosis
- Denosumab 60 mg/ml [Prolia]
- Placebo
-
New York, New YorkColumbia University Irving Medical Center - Harkness Pavillion
Aug 1, 2022
Osteoporosis in Postmenopausal Women Trial (Eldecalcitol, Native Vitamin D, Denosumab)
Not yet recruiting
- Osteoporosis in Postmenopausal Women
- Eldecalcitol
- +3 more
- (no location specified)
Jun 1, 2023
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Follow-up of patients with postmenopausal osteoporosis, with or without
Recruiting
- Osteoporosis, Postmenopausal
- Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
- Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2022
Osteoporosis, Postmenopausal Trial in Stoke (Jumping exercise, Balance exercise (sham control))
Terminated
- Osteoporosis, Postmenopausal
- Jumping exercise
- Balance exercise (sham control)
-
Stoke, England, United KingdomStaffordshire University
Sep 21, 2021
Postmenopausal Osteoporosis, Diabetes Type 2 Trial in Vienna (Prolia, 60 Mg/mL Subcutaneous Solution, Teriparatide)
Active, not recruiting
- Postmenopausal Osteoporosis
- Diabetes Type 2
- Prolia, 60 Mg/mL Subcutaneous Solution
- Teriparatide
-
Vienna, AustriaMedical University Vienna; St. Vincent Hospital
Oct 2, 2021
Diabetes, Type 2 Trial in Hong Kong (Simvastatin 10mg, Ezetimibe 10mg)
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Simvastatin 10mg
- Ezetimibe 10mg
-
Hong Kong, Hong KongDiabetes Centre, 2/F, Block L, Department of Medicine, Queen Mar
Nov 21, 2022
Postmenopausal Osteoporosis Trial in Boston (Romosozumab, Denosumab)
Recruiting
- Postmenopausal Osteoporosis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2022